Dunad Therapeutics
London
About Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: dunad.co.uk
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/dunad-therapeutics-34121 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.